SAGE THERAPEUTICS INC (SAGE)

US78667J1088 - Common Stock

13.69  +0.11 (+0.81%)

After market: 13.69 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
91.07M86.45M7.70M6.30M1.11B
Cost Of Goods
3.19M2.16M800.00K600.00K600.00K
Gross Profit
87.89M84.30M6.90M5.80M1.11B
Operating Expenses
596.55M630.76M553.90M466.60M489.70M
Research and Development
335.16M356.24M326.20M283.20M292.70M
Selling, General, and Administrative Expenses
261.38M274.52M227.70M183.50M197.00M
Operating Income
-508.66M-546.46M-547.00M-460.90M623.90M
Interest Income/Expense
39.17M38.74M14.20M2.90M9.60M
Other Income/Expense
-211.00K-383.00K0.00100.00K300.00K
Non Recurring Items
N/A-33.39M0.000.00-27.70M
Income Before Taxes
-503.09M-541.49M-532.80M-457.90M606.10M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-503.09M-541.49M-532.80M-457.90M606.10M
EBITDA
-507.23M-545.07M-545.90M-456.70M626.50M
 
Per Share Data
EPS Diluted Total Ops
-8.40-9.05-8.98-7.8011.43
Non GAAP EPS
-9.65-10.31-8.98-7.8011.64
 
Statistics
Gross Profit Margin
96.50%97.50%89.61%92.06%99.95%
Profit Margin
-552.40%-626.32%-6919.48%-7268.25%54.40%
Operating Profit Margin
-558.52%-632.08%-7103.90%-7315.87%56.00%

All data in USD

Charts